| 8 | 1/1 | 返回列表 |
| 查看: 2035 | 回復(fù): 7 | ||||
古可ぷ榮譽版主 (文壇精英)
|
[交流]
FDA延遲批準(zhǔn)葛蘭素史克GLP-1藥物阿必魯肽 已有4人參與
|
|
信息來源:http://www.reuters.com/article/2 ... USBRE9710Q620130802 原標(biāo)題:葛蘭素史克糖尿病藥面臨U.S.的延遲批準(zhǔn) (路透社)-英國最大制藥商周五稱,U.S.監(jiān)管部門已經(jīng)將葛蘭素史克實驗性糖尿病藥物阿必魯肽的批準(zhǔn)決定推遲3個月至2014年4月15日。 該藥在歐洲按計劃進行申請。該藥用于2型糖尿病,每周治療一次,與諾和諾德利拉魯肽,百時美施貴寶和阿斯利康的Byetta及 Bydureon屬于同類注射型人胰升血糖素樣肽-1(GLP-1)藥物。 基于臨床試驗結(jié)果報道,業(yè)內(nèi)分析師懷疑阿必魯肽在擁擠的市場能分到多少份額,特別是面臨同線新潛在對手禮來的度拉魯肽。 GLP-1類藥物在臨床上的受限于人體自身產(chǎn)生的GLP-1 易被體內(nèi)的二肽基肽酶Ⅳ(DPP-Ⅳ)降解,其血漿半衰期不足2分鐘,必須持續(xù)靜脈滴注或持續(xù)皮下注射才能產(chǎn)生療效,大大限制它的臨床應(yīng)用。阿必魯肽為二肽基肽酶拮抗胰高血糖素樣肽二聚體人血清蛋白融合物,半衰期4-7天,在半衰期上比已經(jīng)上市的GLP-1類藥物艾塞那肽和利拉魯肽有優(yōu)勢。該藥在美日共進行22項臨床研究包括有效性安全性以及藥物相互作用等http://clinicaltrials.gov/ct2/re ... lutide&pg=1 ,推遲批準(zhǔn)的原因是?有高人解答否? GlaxoSmithKline diabetes drug faces U.S. approval delay (Reuters) - U.S. regulators have pushed back an approval decision on GlaxoSmithKline's experimental diabetes drug albiglutide by three months until April 15, 2014, Britain's biggest drugmaker said on Friday. A separate filing for the drug in Europe is progressing on schedule. The once-weekly treatment for type 2 diabetes belongs to the same class of injectable GLP-1 drugs as Victoza, from Novo Nordisk, and Byetta and Bydureon, from Bristol-Myers Squibb and AstraZeneca. Based on reported clinical trial results, industry analysts have questioned how well albiglutide will fare in a crowded market - especially with a promising new rival in the pipeline in the form of Eli Lilly's dulaglutide. (Reporting by Ben Hirschler; Editing by Keith Weir) |
新藥動態(tài) |


榮譽版主 (文壇精英)

榮譽版主 (文壇精英)


新蟲 (初入文壇)

新蟲 (初入文壇)

| 8 | 1/1 | 返回列表 |
| 最具人氣熱帖推薦 [查看全部] | 作者 | 回/看 | 最后發(fā)表 | |
|---|---|---|---|---|
|
[考研] 0703化學(xué)調(diào)劑 +8 | 妮妮ninicgb 2026-03-15 | 12/600 |
|
|---|---|---|---|---|
|
[考研] 321求調(diào)劑 +3 | 何潤采123 2026-03-18 | 3/150 |
|
|
[考研] 材料專碩英一數(shù)二306 +4 | z1z2z3879 2026-03-18 | 4/200 |
|
|
[考研] 331求調(diào)劑(0703有機化學(xué) +7 | ZY-05 2026-03-13 | 8/400 |
|
|
[考研] 312求調(diào)劑 +8 | 陌宸希 2026-03-16 | 9/450 |
|
|
[考研] 0703化學(xué)調(diào)劑 +4 | pupcoco 2026-03-17 | 7/350 |
|
|
[考研]
|
胡辣湯放糖 2026-03-15 | 6/300 |
|
|
[考研] 0703化學(xué)調(diào)劑 +3 | 妮妮ninicgb 2026-03-17 | 3/150 |
|
|
[考研] 333求調(diào)劑 +3 | 文思客 2026-03-16 | 7/350 |
|
|
[考研] 中科院材料273求調(diào)劑 +4 | yzydy 2026-03-15 | 4/200 |
|
|
[考研] 085600材料與化工 求調(diào)劑 +13 | enenenhui 2026-03-13 | 14/700 |
|
|
[考研] 0703 物理化學(xué)調(diào)劑 +3 | 我可以上岸的對?/a> 2026-03-13 | 5/250 |
|
|
[考研] 294求調(diào)劑 +3 | Zys010410@ 2026-03-13 | 4/200 |
|
|
[考研] 085601材料工程315分求調(diào)劑 +3 | yang_0104 2026-03-15 | 3/150 |
|
|
[考研] 328求調(diào)劑 +3 | 5201314Lsy! 2026-03-13 | 6/300 |
|
|
[考研] 330求調(diào)劑 +3 | ?醬給調(diào)劑跪了 2026-03-13 | 3/150 |
|
|
[考研] 一志愿211化學(xué)學(xué)碩310分求調(diào)劑 +8 | 努力奮斗112 2026-03-12 | 9/450 |
|
|
[考研] 274求調(diào)劑 +3 | S.H1 2026-03-12 | 3/150 |
|
|
[考研] 0817化學(xué)工程與技術(shù)考研312分調(diào)劑 +3 | T123 tt 2026-03-12 | 3/150 |
|
|
[考研] 290求調(diào)劑 +3 | ADT 2026-03-13 | 3/150 |
|